A Cohort Study Exploring Determinants of Safety-Related Regulatory Actions for Biopharmaceuticals

ISSN： 0114-5916

Source： Drug Safety, Vol.35, Iss.5, 2012-05, pp. : 417-427

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

By Heemstra Harald E.

Drug Safety, Vol. 33, Iss. 2, 2010-02 ,pp. : 127-137

Adis International

Access to resources Recommend Favorite

Assessment of Postmarketing Safety-Related Regulatory Actions in Japan

By Ogami Tetsuro Imaizumi Takayuki

Pharmaceutical Medicine, Vol. 26, Iss. 6, 2012-12 ,pp. : 395-403

Adis International

Access to resources Recommend Favorite

Impact of Safety-Related Regulatory Action on Clinical Practice: A Systematic Review

By Piening Sigrid

Drug Safety, Vol. 35, Iss. 5, 2012-05 ,pp. : 373-385

Adis International

Access to resources Recommend Favorite

A Decade of Safety-Related Regulatory Action in the Netherlands: A Retrospective Analysis of Direct Healthcare Professional Communications from 1999 to 2009

By Mol Peter G.M. Straus Sabine M.J.M. Piening Sigrid de Vries Jonie T.N. de Graeff Pieter A. Haaijer-Ruskamp Flora M.

Drug Safety, Vol. 33, Iss. 6, 2010-06 ,pp. : 463-474

Adis International

Access to resources Recommend Favorite

Discontinuation of Cholinesterase Inhibitor Treatment and Determinants thereof in the Netherlands: A Retrospective Cohort Study

By Kröger Edeltraut >

Drugs & Aging, Vol. 27, Iss. 8, 2010-08 ,pp. : 663-675

Adis International

Access to resources Recommend Favorite